PMID- 16928501 OWN - NLM STAT- MEDLINE DCOM- 20060913 LR - 20191210 IS - 1552-6259 (Electronic) IS - 0003-4975 (Linking) VI - 82 IP - 3 DP - 2006 Sep TI - Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication? PG - 879-88; discussion 888 AB - BACKGROUND: Surgical ventricular restoration (SVR) is an established therapy for congestive heart failure due to ischemic cardiomyopathy. Pulmonary hypertension (PHTN) has been considered a contraindication for SVR owing to a presumed increase in operative risk. However, outcomes in these patients and the impact of SVR on PHTN have not been specifically evaluated. METHODS: We retrospectively reviewed SVR patients between January 2002 and June 2005. Patients were classified as PHTN (mean pulmonary artery pressure > or = 25 mm Hg) and no PHTN (mPAP < 25 mm Hg) based on preoperative cardiac catheterization. Cardiac function was assessed using magnetic resonance imaging and echocardiography. Follow-up was 100%. RESULTS: Sixty-nine patients underwent SVR for congestive heart failure. Thirty-six percent (25 of 69) had preoperative PHTN. Preoperatively, PHTN patients had significantly lower ejection fraction (21.1% versus 30.0%; p = 0.005) and larger left ventricular end-systolic volume index (119.0 versus 88.7 mL/m2; p = 0.04) than patients without PHTN. All PHTN patients and 95.5% (42 of 44) of the no PHTN group were New York Heart Association (NYHA) class III/IV preoperatively. There was 1 operative death in the PHTN group. Surgical ventricular restoration significantly improved cardiac function and pulmonary pressures for PHTN patients. Both groups had similar cardiac function postoperatively. Seventy-two percent (18 of 25) of PHTN patients and 69.0% (29 of 42) of patients without PHTN improved to NYHA class I/II at follow-up. Kaplan-Meier survival of PHTN patients was 68.1% at 3 years, which was lower than patients without PHTN (81.4%; p = 0.44), but not statistically significant. Kaplan-Meier 3-year survival for all SVR patients was 76.6%. CONCLUSIONS: Surgical ventricular restoration is a good treatment option in patients with advanced congestive heart failure and PHTN. Our early results are promising and should prompt further studies to confirm these findings. FAU - Patel, Nishant D AU - Patel ND AD - Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. FAU - Williams, Jason A AU - Williams JA FAU - Nwakanma, Lois U AU - Nwakanma LU FAU - Waldron, Michele M AU - Waldron MM FAU - Bluemke, David A AU - Bluemke DA FAU - Conte, John V AU - Conte JV LA - eng PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Ann Thorac Surg JT - The Annals of thoracic surgery JID - 15030100R SB - IM MH - Aged MH - *Cardiac Surgical Procedures MH - Comorbidity MH - Contraindications MH - Coronary Artery Bypass/statistics & numerical data MH - Female MH - Heart Failure/complications/*surgery MH - Heart Ventricles/*surgery MH - Humans MH - Hypertension, Pulmonary/*complications MH - Length of Stay/statistics & numerical data MH - Male MH - Middle Aged MH - Mitral Valve Insufficiency/complications/surgery MH - Postoperative Complications/epidemiology MH - Proportional Hazards Models MH - Retrospective Studies MH - Risk MH - Stroke Volume MH - Treatment Outcome EDAT- 2006/08/25 09:00 MHDA- 2006/09/14 09:00 CRDT- 2006/08/25 09:00 PHST- 2006/01/27 00:00 [received] PHST- 2006/03/31 00:00 [revised] PHST- 2006/04/03 00:00 [accepted] PHST- 2006/08/25 09:00 [pubmed] PHST- 2006/09/14 09:00 [medline] PHST- 2006/08/25 09:00 [entrez] AID - S0003-4975(06)00708-9 [pii] AID - 10.1016/j.athoracsur.2006.04.016 [doi] PST - ppublish SO - Ann Thorac Surg. 2006 Sep;82(3):879-88; discussion 888. doi: 10.1016/j.athoracsur.2006.04.016.